by ODWAdmin | Jan 23, 2025
Sex-Based Metabolomic Differences in Checkpoint Inhibitor Response This poster from our partners at TD2 (Translational Drug Development) highlights significant differences in tumor growth inhibition and treatment responses between obese and control diet-fed mice. Dive...
by Janine Rodriguez | Jan 14, 2025
Integrated multi-omics unlocks holistic phenotypic insights allowing for deep molecular exploration The omics era has greatly expanded the repertoire of approaches available for researchers and clinicians to unravel the complexity underpinning human health: Next...
by ODWAdmin | Jun 11, 2024
Integration of untargeted metabolomics with targeted profiling of inflammatory proteins to define the metabolic fingerprint of inflammation in COVID-19 Integrated multi-omics provides enhanced mechanistic insight through broader and deeper biochemical pathway...
by ODWAdmin | Jun 11, 2024
Integrated Proteomics, Metabolomics, and Transcriptomics Reveals Systemic and Localized Metabolic Disruptions in Colorectal Cancer When integrating multiple sets of -omics data, a more comprehensive view of the underlying mechanisms of cancer is enabled. This poster...
by ODWAdmin | Jun 11, 2024
Integrated Metabolomics and Proteomics Profiling of Human Serum Reveals an Age-Associated Molecular Signature Panome Bio’s Next-Generation Metabolomics™️ platform provides an unbiased and global view of metabolism. When integrated with other -omics data, a more...
